Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval

New Delhi: The price of Covishield and Covaxin, two Covid-19 vaccines which have been granted Emergency…

Government expert panel recommends regular market approval for Covishield, Covaxin

Image Source: File Photo representative image. Highlight A DCGI Committee Recommends Regular Market Approval to Covishield…

Government panel recommends regular market approval for Covishield and Covaxin

New Delhi: An expert panel of India’s federal drug regulator on Wednesday recommended allowing regular market…

New Oxford trial to gather more data on side effects, benefits of anti-Covid pill mollupiravir: Experts

The United Kingdom is set to launch another trial to generate more data on the benefits…

Bharat Biotech gets nod to test nasal COVID-19 shot as booster: Report India News – Times of India

BENGALURU: India’s drug regulator on Wednesday approved Bharat Biotech To test the late stage of its…

DCGI approves Bharat Biotech for Phase 3 ‘Booster Dose Study’ for Intranasal Vaccine

New Delhi: The Drug Controller General of India (DCGI) Subject Expert Committee (SEC) has given ‘in-principle’…

SII gets DCGI nod to make drug substance, test it to develop jab against Omicron

New Delhi India’s drug regulator on Friday approved the Serum Institute of India’s proposal to make…

5 days treatment of Kovid pill Molnupiravir can cost from Rs 1,600 to Rs 3,000

Molnupiravir, an anti-viral Covid pill, may cost Rs 40 to Rs 75 per tablet, taking the…

Vaccines for 15-18 age group, third ‘precautionary dose’ for healthcare workers and 60-plus from January, PM Modi announces

In a surprise Christmas address, Prime Minister Narendra Modi announced that India will begin immunization of…

DCGI seeks more data from SII on its application seeking emergency authorization for Covovax

Official sources said on Thursday that the Drug Controller General of India (DCGI) has raised questions…